CNCE Historical Earnings image   This CNCE historical earnings page last updated 8/8/2022
CNCE Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.02M
Q1 20225/5/2022NA
Q4 20213/3/20220.01M
Q3 202111/9/20210.00B
Q2 20218/5/20210.03B
Q1 20215/4/20210.01M
Q4 20202/25/20210.01M
Q3 202011/5/20200.00B
Q2 20208/6/20200.01B
Q1 20204/30/20200.01M
Q4 20192/27/20200.01M
Q3 201911/7/20190.01M
Q2 20198/1/20190.05M
Q1 20195/2/20190.00B
Q4 20182/28/201913000
Q3 201811/1/201811000
Q2 20188/2/20182000
Q1 20185/3/201810.48M
Q4 20173/1/201812000
Q3 201711/9/2017143.84M
Q2 20178/8/201715000
Q1 20175/2/201720000
Q4 20163/6/201721000
Q3 201611/8/201626000
Q2 20168/9/201671000
Q1 20165/5/201656000
Q4 20153/1/201610.30M
Q3 201511/5/20151.71M
Q2 20158/5/20153.25M
Q1 20155/8/20151.31M
Q4 20142/3/20151.31M
Q3 201411/12/20144.42M
Q2 20148/12/20141.24M
Q1 20145/14/20141.61M
FY 20133/31/201425.40M
CNCE Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/4/2022-0.590
Q1 20225/5/2022-1.030
Q4 20213/3/2022-1.010
Q3 202111/9/2021-0.780
Q2 20218/5/20210.160
Q1 20215/4/2021-0.670
Q4 20202/25/2021-0.690
Q3 202011/5/2020-0.600
Q2 20208/6/2020-0.410
Q1 20204/30/2020-0.700
Q4 20192/27/2020-0.860
Q3 201911/7/2019-0.720
Q2 20198/1/2019-0.780
Q1 20195/2/2019-0.930
Q4 20182/28/2019-0.89
Q3 201811/1/2018-0.74
Q2 20188/2/2018-0.57
Q1 20185/3/2018-0.19
Q4 20173/1/2018-0.26
Q3 201711/9/20175.44
Q2 20178/8/2017-0.58
Q1 20175/2/2017-0.6
Q4 20163/6/2017-0.54
Q3 201611/8/2016-0.51
Q2 20168/9/2016-0.6
Q1 20165/5/2016-0.63
Q4 20153/1/20160.03
Q3 201511/5/2015-0.39
Q2 20158/5/2015-0.37
Q1 20155/8/2015-0.48
Q4 20142/3/2015-0.56
Q3 201411/12/2014-0.43
Q2 20148/12/2014-0.45
Q1 20145/14/2014-0.76
FY 20133/31/2014-4.99
Quotes delayed 20 minutes

Email EnvelopeFree CNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Concert Pharmaceuticals (CNCE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CNMD Historical Earnings
CNSP Historical Earnings
CNST Historical Earnings
CNTX Historical Earnings
CNVY Historical Earnings
COCP Historical Earnings
CODX Historical Earnings
COGT Historical Earnings
COLL Historical Earnings
COO Historical Earnings
What was the record high CNCE historical earnings result?
In terms of earnings or revenue, what is the best CNCE historical earnings result that Concert Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CNCE historical earnings result was set in Q3 2017, when Concert Pharmaceuticals posted results of 5.44/share. The most successful revenue quarter within our data set was Q3 2017 when Concert Pharmaceuticals reported revenue of 143.84M.

What was the lowest Concert Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CNCE has reported, and when?

✔️Accepted answer: Within our data set, the lowest CNCE historical earnings result was set in FY 2013, when Concert Pharmaceuticals posted results of -4.99/share. The smallest revenue quarter within our data set was Q1 2022 when Concert Pharmaceuticals reported revenue of NA.

On this page we presented the CNCE historical earnings date information for Concert Pharmaceuticals. Reviewing that CNCE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2017, when CNCE posted gaap of 5.44/share. Meanwhile the lowest CNCE historical earnings result was in FY 2013, when CNCE posted gaap of -4.99/share. Moving to Concert Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2017 when CNCE reported 143.84M in revenue, while the smallest revenue quarter was Q1 2022 when CNCE reported NA in revenue.

For self directed investors doing their due diligence on CNCE or any other given stock, their research can benefit from looking into all of the Concert Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Concert Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CNCE. Thanks for visiting, and the next time you need to research CNCE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: GLNG Historical Stock Prices, KBH Insider Buying, BRKL Average Annual Return.

 

CNCE Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.